Skip to content

Analysis of the clinical efficacy and safety of superpulsed thulium laser powder lithotripsy and traditional holmium laser lithotripsy in the treatment of upper urinary tract stones: a randomized, positive-controlled, blinded management, single-center trial

Analysis of the clinical efficacy and safety of superpulsed thulium laser powder lithotripsy and traditional holmium laser lithotripsy in the treatment of upper urinary tract stones: a randomized, positive-controlled, blinded management, single-center trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076893
Enrollment
Unknown
Registered
2023-10-24
Start date
2023-10-24
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary calculus

Interventions

Experimental group:Superpulse thulium laser group
Control group:Holmium laser group

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) Age = 18 years old, 2) Patients with upper urinary tract stones who have been evaluated by color Doppler ultrasound, abdominal CT scan, or other examinations and meet the surgical indications, 3) The patient has no urinary tract infection before surgery or the infection has been controlled, 4) Excluding urinary system abnormalities on the surgical side, 5) Regularly cooperate with treatment and follow-up, 6) Can sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients who do not meet the inclusion criteria, 2) Patients who participate in other clinical trials, 3) Pregnant women, 4) Patients with severe cardiovascular or respiratory diseases, 5) Preoperative complications of uncontrolled urinary tract infections, 6) Abnormal anatomical structure of the affected urinary system, 7) Individuals with a history of mental illness, 8) Those with poor compliance and inability to complete treatment and follow-up.

Design outcomes

Primary

MeasureTime frame
calculus clearance rate;

Secondary

MeasureTime frame
surgery time;intraoperative laser usage time;postoperative hospitalization time;postoperative clinical indicators;total hospitalization expenses;secondary calculus clearance rate;perioperative complications;average hemoglobin decrease level;average level of white blood cell elevation;

Countries

China

Contacts

Public ContactPang Cheng

Beijing Hospital

haseo_pc@126.com+86 10 8513 6272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026